Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Cortes

Showing results (221-230 of 232) with videos related to

Pageof 24
Sort By:
Cancers|September 10, 2021
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast CancerFrancesco Schettini, Mario Giuliano, Matteo Lambertini, et al.
Cell|September 20, 2016
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer CompoundsAlejandra Bruna, Oscar M Rueda, Wendy Greenwood, et al.
The New England Journal of Medicine|February 9, 2022
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast CancerPeter Schmid, Javier Cortes, Rebecca Dent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT TrialPeter Schmid, Jacinta Abraham, Stephen Chan, et al.
Nature Communications|November 12, 2015
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasmaLeticia De Mattos-Arruda, Regina Mayor, Charlotte K Y Ng, et al.
NPJ Breast Cancer|June 8, 2026
SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancerFrançois-Clement Bidard, Carlos Barrios, Giampaolo Bianchini, et al.
Nature Genetics|February 10, 2015
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapiesLuping Lin, Amit J Sabnis, Elton Chan, et al.
Cell Reports|May 30, 2019
The Genomic and Immune Landscapes of Lethal Metastatic Breast CancerLeticia De Mattos-Arruda, Stephen-John Sammut, Edith M Ross, et al.
Nature Cell Biology|April 21, 2018
Publisher Correction: MSK1 regulates luminal cell differentiation and metastatic dormancy in ER<sup>+</sup> breast cancerSylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.
Nature Cell Biology|January 24, 2018
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER<sup>+</sup> breast cancerSylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.
Pageof 24

Showing results (221-230 of 232) with videos related to

Sort By:
Pageof 24
Cancers|September 10, 2021
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast CancerFrancesco Schettini, Mario Giuliano, Matteo Lambertini, et al.
Cell|September 20, 2016
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer CompoundsAlejandra Bruna, Oscar M Rueda, Wendy Greenwood, et al.
The New England Journal of Medicine|February 9, 2022
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast CancerPeter Schmid, Javier Cortes, Rebecca Dent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT TrialPeter Schmid, Jacinta Abraham, Stephen Chan, et al.
Nature Communications|November 12, 2015
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasmaLeticia De Mattos-Arruda, Regina Mayor, Charlotte K Y Ng, et al.
NPJ Breast Cancer|June 8, 2026
SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancerFrançois-Clement Bidard, Carlos Barrios, Giampaolo Bianchini, et al.
Nature Genetics|February 10, 2015
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapiesLuping Lin, Amit J Sabnis, Elton Chan, et al.
Cell Reports|May 30, 2019
The Genomic and Immune Landscapes of Lethal Metastatic Breast CancerLeticia De Mattos-Arruda, Stephen-John Sammut, Edith M Ross, et al.
Nature Cell Biology|April 21, 2018
Publisher Correction: MSK1 regulates luminal cell differentiation and metastatic dormancy in ER<sup>+</sup> breast cancerSylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.
Nature Cell Biology|January 24, 2018
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER<sup>+</sup> breast cancerSylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.
Pageof 24